Himanshu Mahana

Laboratory Investigation Report
Patient Name : Mr. Himanshu Centre : 3810 - Shakuntalam Hospital

Age/Gender : 19 Y 11 M 14 D /M OP/IP No : OP/0665/23
Max ID/Mobile : ML02327603/8930179934 Collection Date/Time : 05/Nov/2023 03:08PM
Lab ID : 3589102200091 Receiving Date : 05/Nov/2023
Ref Doctor : Dr.Sidharth Yadav Reporting Date : 05/Nov/2023
Passport No. :
Hematology
CBC (Complete Blood Count)*, Whole Blood EDTA

Date 05/Nov/23 21/Oct/23 03/Oct/23 Unit Bio Ref Interval
03:08PM 11:00AM 11:54AM
Haemoglobin 14.1 14.6 15.9 g/dl 13.0 - 17.0
Modified cyanmethemoglobin
Packed Cell, Volume 46.9 43.4 47.5 % 40-50
Calculated
Total Leucocyte Count 9.43 9.8 8.8 10~9/L 4.0-10.0
(TLC)
Electrical Impedance
RBC Count 5.29 5.1 5.5 10~12/L 4.5-5.5
MCV 88.7 85.9 86.7 fL 83-101
MCH 26.7 28.9 29 pg 27-32
Calculated
MCHC 30.1 33.6 33.5 g/dl 31.5-34.5
Calculated
Platelet Count 543 407 546 10~9/L 150-410
MPV 8.6 fl 7.8-11.2
Calculated
RDW 12.6 12.7 12.8 % 11.5-14.5
Calculated
Differential Cell Count

VCS / Light Microscopy
Neutrophils 59 56 53 % 40-80
Lymphocytes 31 34 35 % 20-40
Monocytes 08 06 07 % 2-10
Eosinophils 02 04 05 % 1-6
Basophils 00 00 00 % 0-2
Absolute Leukocyte Count

Calculated from TLC & DLC
Absolute Neutrophil Count 5.56 5.49 4.66 10~9/L 2.0-7.0

Absolute Lymphocyte 2.9 3.3 3.1 10~9/L 1.0-3.0
Count
Absolute Monocyte Count 0.75 0.59 0.62 10~9/L 0.2-1.0
Page 1 of 6
SIN No:B2B2470359, Test Performed at :3770 - Kalawati Hospital, Kalawati Hospital , Shiv Chowk , 200 Model Tow
Booking Centre :3810 - Shakuntalam Hospital, Shop No 48-51, Maharana Pratap Chowk Bawal Road
The authenticity of the report can be verified by scanning the Q R Code on top of the page

Passport No. :
Hematology
Absolute Eosinophil Count 0.19 0.39 0.44 10~9/L 0.02-0.5
Kindly correlate with clinical findings
*** End Of Report ***
Page 2 of 6

Passport No. :
Molecular Diagnostics
Test Name Result Unit Bio Ref Interval
PCR FOR HLA B27,EDTA*, EDTA

Real Time PCR
HLA B27 Positive Negative

PCR-SSP
Comment
Certain inflammatory and non-inflammatory diseases are associated with the inheritance of HLA alleles. Ankylosing
spondylitis and several postinfectious arthropathies are associated with the presence of HLA -B27. Individuals who inherit
this class I allele have a 90 fold greater chance of developing the disease as compared to those who do not carry HLA-
B27.
This is a lab developed test and its performance characteristics have been determined inhouse as per recommended
International standards. An Internal control in the form of a house keeping gene is co-amplified to check for adequate DNA
extraction. This test is performed along with recommended controls to maintain the quality of the assay.
In cases of HLA-B27 negative Spondyloarthropathy, the further testing recommended is “HLA-C*06” (Positive
in Psoriatic arthritis) and HLA-B*07 (Positive in Juvenile and Undifferentiated Spondyloarthropathy).
Uses :
==========================================================================
DISEASES STRENGTH OF ASSOCIATION
==========================================================================
Ankylosing spondylitis ++++
Reiters syndrome ++++
Reactive arthiritis( Yersinia, Salmonella, Shigella& Chlamydia) +++
Acute anterior uveitis +++
Psoriatic spondylitis +++
==========================================================================
Page 3 of 6
SIN No:B2B2470359, Test Performed at :910 - Max Hospital - Saket M S S H, Press Enclave Road, Mandir Marg, Saket, New Delhi, Delhi
110017

Passport No. :
Molecular Diagnostics
Test Name Result Unit Bio Ref Interval
Page 4 of 6
SIN No:B2B2470359, Test Performed at :910 - Max Hospital - Saket M S S H, Press Enclave Road, Mandir Marg, Saket, New Delhi, Delhi
110017

Passport No. :
Clinical Biochemistry
LFT Screening
Liver Function Test (LFT)*, Serum

Date 05/Nov/2023 Unit Bio Ref Interval
03:08PM
Total Protein 8.00 g/dL 6.3–8.2
Biuret
Albumin 4.2 g/dl 3.5-5.2
BCG
Globulin 3.8 g/dl 2.3 - 3.5
Calculated
A.G. ratio 1.1 1.2 - 1.5
Calculated
Bilirubin (Total) 0.5 mg/dl 0.2–1.3
Diazo
Bilirubin (Direct) 0.2 mg/dl 0-0.3
Diazo
Bilirubin (Indirect) 0.30 mg/dL 0.1 - 1.0
Calculated
SGOT- Aspartate 17.0 U/L 0-40
Transaminase (AST)
IFCC without pyridoxal phosphate
SGPT- Alanine 20.0 U/L 0-50
Transaminase (ALT)
IFCC without pyridoxal phosphate
AST/ALT Ratio 0.85 Ratio
Calculated
Alkaline Phosphatase 76.0 U/L 38 - 126
pNPP
Interpretation AST/ALT Ratio : -

In Case of deranged AST and/or ALT, the AST/ALT ratio is < 2.0 in alcoholic liver damage and > 2.0 in non – alcoholic liver damage

Page 5 of 6

Passport No. :
Clinical Biochemistry
LFT Screening
Page 6 of 6

Himanshu Mahana

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Himanshu Mahana

Uploaded by

Copyright:

Available Formats

Laboratory Investigation Report

Patient Name : Mr. Himanshu Centre : 3810 - Shakuntalam Hospital

CBC (Complete Blood Count)*, Whole Blood EDTA

Differential Cell Count

Absolute Leukocyte Count

Absolute Neutrophil Count 5.56 5.49 4.66 10~9/L 2.0-7.0

Patient Name : Mr. Himanshu Centre : 3810 - Shakuntalam Hospital

Absolute Eosinophil Count 0.19 0.39 0.44 10~9/L 0.02-0.5

Kindly correlate with clinical findings

* End Of Report *

Patient Name : Mr. Himanshu Centre : 3810 - Shakuntalam Hospital

PCR FOR HLA B27,EDTA*, EDTA

HLA B27 Positive Negative

Kindly correlate with clinical findings

* End Of Report *

Patient Name : Mr. Himanshu Centre : 3810 - Shakuntalam Hospital

Patient Name : Mr. Himanshu Centre : 3810 - Shakuntalam Hospital

Liver Function Test (LFT)*, Serum

Interpretation AST/ALT Ratio : -

Kindly correlate with clinical findings

Patient Name : Mr. Himanshu Centre : 3810 - Shakuntalam Hospital

You might also like